9.6895
Neogenomics Inc (NEO) 最新ニュース
NeoGenomics (NASDAQ:NEO) Stock Price Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat
NeoGenomics (NEO) CFO Abhishek Jain granted options and RSUs - Stock Titan
Oversold Conditions For NeoGenomics (NEO) - Nasdaq
NEO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Earnings are out: How did SWFL companies perform? - Naples Daily News
Natera, NeoGenomics Unit End Patent Suit Over Lung Cancer Test - Bloomberg Law News
3 Reasons to Avoid NEO and 1 Stock to Buy Instead - Finviz
(NEO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tu - PharmiWeb.com
NeoGenomics Launches RaDaR ST Molecular Residual Disease Test - marketscreener.com
NeoGenomics, Inc. Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types - marketscreener.com
NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types - The Joplin Globe
NeoGenomics, Inc. Trade Ideas — FWB:NG9 - TradingView
NeoGenomics outlines $793M–$801M 2026 revenue target as RaDaR ST and PanTracer initiatives gain traction - MSN
NeoGenomics (NEO) COO logs RSU vesting and tax share withholding - Stock Titan
Equity moves for NeoGenomics (NASDAQ: NEO) CFO Jeffrey Sherman - Stock Titan
NeoGenomics (NEO) EVP nets new shares from RSU vesting and tax withholding - Stock Titan
NeoGenomics (NEO) CAO converts RSUs to stock and withholds shares for taxes - Stock Titan
NeoGenomics, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Indicators - Markets Mojo
5 Insightful Analyst Questions From NeoGenomics's Q4 Earnings Call - Finviz
NeoGenomics, Inc. (NEO) Stock Analysis: A 47% Upside Potential in the Healthcare Diagnostics Sector - DirectorsTalk Interviews
5 Insightful Analyst Questions From NeoGenomics’s Q4 Earnings Call - Yahoo Finance
Market Catalysts: What are Calix Incs technical support levelsMarket Trend Report & Verified Momentum Watchlists - baoquankhu1.vn
NeoGenomics (NEO) Q4 2025 Earnings Call Transcript - AOL.com
NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
NeoGenomics (NASDAQ:NEO) Gains Traction In Nasdaq Index Mid-Cap Healthcare - Kalkine Media
Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness - Yahoo Finance
NeoGenomics, Inc. $NEO Shares Bought by White Pine Capital LLC - MarketBeat
NeoGenomics, Inc. $NEO Stock Holdings Lifted by Aberdeen Group plc - MarketBeat
Short Squeeze: What is the PEG ratio of Brookdale Senior Living IncStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for NeoGenomics (NEO) - Finviz
NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference - ACCESS Newswire
Why is NeoGenomics Inc. stock going upM&A Rumor & Free High Accuracy Swing Entry Alerts - mfd.ru
UBS Maintains Hold on NeoGenomics, Inc. (NEO) on Feb 18, 2026 - Meyka
Needham & Company LLC Forecasts Strong Price Appreciation for NeoGenomics (NASDAQ:NEO) Stock - Defense World
NeoGenomics Q4 Earnings Call Highlights - Defense World
NeoGenomics Faces High-Stakes Risk as Test Reliability and Diagnostic Errors Threaten Reputation and Legal Exposure - TipRanks
NeoGenomics (NASDAQ:NEO) Trading Down 8.9%Should You Sell? - MarketBeat
NeoGenomics (NEO) Stock Drops After 2026 Outlook Misses ExpectationsNews and Statistics - IndexBox
Weekly Trades: Will ChoiceOne Financial Services Inc benefit from green energy policies2025 Performance Recap & Fast Moving Market Watchlists - baoquankhu1.vn
Why NeoGenomics (NEO) Shares Are Falling Today - Finviz
NeoGenomics, Inc. (NASDAQ:NEO) Q4 2025 Earnings Call Transcript - Insider Monkey
NeoGenomics to Participate in Upcoming Investor Conferences - The Joplin Globe
NEO Q4 Deep Dive: Product Mix Shift and Guidance Weigh on Outlook - Finviz
NeoGenomics Q4 2025 slides: 11% revenue growth, RaDaR ST launch imminent - Investing.com South Africa
Labcorp (LH) Q4 2025 Earnings Call Transcript - AOL.com
NeoGenomics PanTracer Pro Launch Adds New Dimension To Growth Story - Yahoo Finance
NeoGenomics slides more than 5% despite fourth-quarter earnings beat - MSN
NeoGenomics Earnings Call Signals Growth With Caveats - TipRanks
MSN Money - MSN
Needham raises Neogenomics stock price target on 2027 estimates - Investing.com Australia
Needham raises Neogenomics stock price target on 2027 estimates By Investing.com - Investing.com South Africa
大文字化:
|
ボリューム (24 時間):